Survival on home dialysis in New Zealand.

<h4>Background</h4>New Zealand (NZ) has a high prevalence of both peritoneal dialysis (PD) and home haemodialysis (HD) relative to other countries, and probably less selection bias. We aimed to determine if home dialysis associates with better survival than facility HD by simultaneous co...

Full description

Bibliographic Details
Main Authors: Mark R Marshall, Rachael C Walker, Kevan R Polkinghorne, Kelvin L Lynn
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24806458/pdf/?tool=EBI
id doaj-8f78c1b922a043f3b35bb345572e0e06
record_format Article
spelling doaj-8f78c1b922a043f3b35bb345572e0e062021-03-04T09:27:27ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0195e9684710.1371/journal.pone.0096847Survival on home dialysis in New Zealand.Mark R MarshallRachael C WalkerKevan R PolkinghorneKelvin L Lynn<h4>Background</h4>New Zealand (NZ) has a high prevalence of both peritoneal dialysis (PD) and home haemodialysis (HD) relative to other countries, and probably less selection bias. We aimed to determine if home dialysis associates with better survival than facility HD by simultaneous comparisons of the three modalities.<h4>Methods</h4>We analysed survival by time-varying dialysis modality in New Zealanders over a 15-year period to 31-Dec-2011, adjusting for patient co-morbidity by Cox proportional hazards multivariate regression.<h4>Results</h4>We modelled 6,419 patients with 3,254 deaths over 20,042 patient-years of follow-up. Patients treated with PD and facility HD are similar; those on home HD are younger and healthier. Compared to facility HD, home dialysis (as a unified category) associates with an overall 13% lower mortality risk. Home HD associates with a 52% lower mortality risk. PD associates with a 20% lower mortality risk in the early period (<3 years) that is offset by a 33% greater mortality risk in the late period (>3 years), with no overall net effect. There was effect modification and less observable benefit associated with PD in those with diabetes mellitus, co-morbidity, and in NZ Maori and Pacific People. There was no effect modification by age or by era.<h4>Conclusion</h4>Our study supports the culture of home dialysis in NZ, and suggests that the extent and duration of survival benefit associated with early PD may be greater than appreciated. We are planning further analyses to exclude residual confounding from unmeasured co-morbidity and other sociodemographic factors using database linkage to NZ government datasets. Finally, our results suggest further research into the practice of PD in NZ Maori and Pacific People, as well as definitive study to determine the best timing for switching from PD in the late phase.https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24806458/pdf/?tool=EBI
collection DOAJ
language English
format Article
sources DOAJ
author Mark R Marshall
Rachael C Walker
Kevan R Polkinghorne
Kelvin L Lynn
spellingShingle Mark R Marshall
Rachael C Walker
Kevan R Polkinghorne
Kelvin L Lynn
Survival on home dialysis in New Zealand.
PLoS ONE
author_facet Mark R Marshall
Rachael C Walker
Kevan R Polkinghorne
Kelvin L Lynn
author_sort Mark R Marshall
title Survival on home dialysis in New Zealand.
title_short Survival on home dialysis in New Zealand.
title_full Survival on home dialysis in New Zealand.
title_fullStr Survival on home dialysis in New Zealand.
title_full_unstemmed Survival on home dialysis in New Zealand.
title_sort survival on home dialysis in new zealand.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2014-01-01
description <h4>Background</h4>New Zealand (NZ) has a high prevalence of both peritoneal dialysis (PD) and home haemodialysis (HD) relative to other countries, and probably less selection bias. We aimed to determine if home dialysis associates with better survival than facility HD by simultaneous comparisons of the three modalities.<h4>Methods</h4>We analysed survival by time-varying dialysis modality in New Zealanders over a 15-year period to 31-Dec-2011, adjusting for patient co-morbidity by Cox proportional hazards multivariate regression.<h4>Results</h4>We modelled 6,419 patients with 3,254 deaths over 20,042 patient-years of follow-up. Patients treated with PD and facility HD are similar; those on home HD are younger and healthier. Compared to facility HD, home dialysis (as a unified category) associates with an overall 13% lower mortality risk. Home HD associates with a 52% lower mortality risk. PD associates with a 20% lower mortality risk in the early period (<3 years) that is offset by a 33% greater mortality risk in the late period (>3 years), with no overall net effect. There was effect modification and less observable benefit associated with PD in those with diabetes mellitus, co-morbidity, and in NZ Maori and Pacific People. There was no effect modification by age or by era.<h4>Conclusion</h4>Our study supports the culture of home dialysis in NZ, and suggests that the extent and duration of survival benefit associated with early PD may be greater than appreciated. We are planning further analyses to exclude residual confounding from unmeasured co-morbidity and other sociodemographic factors using database linkage to NZ government datasets. Finally, our results suggest further research into the practice of PD in NZ Maori and Pacific People, as well as definitive study to determine the best timing for switching from PD in the late phase.
url https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24806458/pdf/?tool=EBI
work_keys_str_mv AT markrmarshall survivalonhomedialysisinnewzealand
AT rachaelcwalker survivalonhomedialysisinnewzealand
AT kevanrpolkinghorne survivalonhomedialysisinnewzealand
AT kelvinllynn survivalonhomedialysisinnewzealand
_version_ 1714807084356206592